Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra A Springer

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Current HIV/AIDS Reports|September 12, 2023
Integrated Care Models: HIV and Substance UseKatherine Hill, Irene Kuo, Sheela V Shenoi, et al.
The American Journal on Addictions|April 30, 2020
A Literature Review Examining Primary Outcomes of Medication Treatment Studies for Opioid Use Disorder: What Outcome Should Be Used to Measure Opioid Treatment Success?Breanne E Biondi, Xiaoying Zheng, Cynthia A Frank, et al.
Infectious Disease Clinics of North America|July 3, 2024
HIV and Substance Use DisordersAudun J Lier, Adati Tarfa, Sheela V Shenoi, et al.
Journal of Substance Abuse Treatment|August 21, 2022
Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorderAudun J Lier, Nikhil Seval, Brent Vander Wyk, et al.
Addiction Science & Clinical Practice|March 8, 2022
Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the communityBreanne E Biondi, Brent Vander Wyk, Esther F Schlossberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2004
Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the communitySandra A Springer, Edward Pesanti, John Hodges, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 22, 2018
Extended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community: Results From a Double-Blind, Placebo-Controlled TrialSandra A Springer, Angela Di Paola, Russell Barbour, et al.
Journal of Substance Use and Addiction Treatment|June 4, 2023
Corrigendum to 'Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder' [J. Subst. Abuse Treat. vol. 142 (2022)/108852]Audun J Lier, Nikhil Seval, Brent Vander Wyk, et al.
Journal of the International AIDS Society|November 26, 2021
Feasibility of a community-based delivery model for HIV pre-exposure prophylaxis among bar patrons in rural South AfricaMegan A Grammatico, Anthony P Moll, Koeun Choi, et al.
Journal of Substance Abuse Treatment|November 3, 2020
A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorderKatharine Cioe, Breanne E Biondi, Rebecca Easly, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Current HIV/AIDS Reports|September 12, 2023
Integrated Care Models: HIV and Substance UseKatherine Hill, Irene Kuo, Sheela V Shenoi, et al.
The American Journal on Addictions|April 30, 2020
A Literature Review Examining Primary Outcomes of Medication Treatment Studies for Opioid Use Disorder: What Outcome Should Be Used to Measure Opioid Treatment Success?Breanne E Biondi, Xiaoying Zheng, Cynthia A Frank, et al.
Infectious Disease Clinics of North America|July 3, 2024
HIV and Substance Use DisordersAudun J Lier, Adati Tarfa, Sheela V Shenoi, et al.
Journal of Substance Abuse Treatment|August 21, 2022
Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorderAudun J Lier, Nikhil Seval, Brent Vander Wyk, et al.
Addiction Science & Clinical Practice|March 8, 2022
Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the communityBreanne E Biondi, Brent Vander Wyk, Esther F Schlossberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2004
Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the communitySandra A Springer, Edward Pesanti, John Hodges, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 22, 2018
Extended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community: Results From a Double-Blind, Placebo-Controlled TrialSandra A Springer, Angela Di Paola, Russell Barbour, et al.
Journal of Substance Use and Addiction Treatment|June 4, 2023
Corrigendum to 'Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder' [J. Subst. Abuse Treat. vol. 142 (2022)/108852]Audun J Lier, Nikhil Seval, Brent Vander Wyk, et al.
Journal of the International AIDS Society|November 26, 2021
Feasibility of a community-based delivery model for HIV pre-exposure prophylaxis among bar patrons in rural South AfricaMegan A Grammatico, Anthony P Moll, Koeun Choi, et al.
Journal of Substance Abuse Treatment|November 3, 2020
A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorderKatharine Cioe, Breanne E Biondi, Rebecca Easly, et al.
Pageof 13